{"id":9793,"date":"2022-09-26T11:52:01","date_gmt":"2022-09-26T11:52:01","guid":{"rendered":"https:\/\/preprod.oxypharm.net\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/"},"modified":"2025-04-28T09:35:54","modified_gmt":"2025-04-28T09:35:54","slug":"pr-alain-sarasin-diretor-de-investigacao-no-cnrs","status":"publish","type":"post","link":"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/","title":{"rendered":"Pr. Alain Sarasin, Diretor de Investiga\u00e7\u00e3o no CNRS"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_column_text]<\/p>\n<blockquote><p>Num laborat\u00f3rio que analisava os riscos de cancro, o facto de utilizar material considerado cancer\u00edgeno n\u00e3o era uma boa ideia. Esta \u00e9 uma das raz\u00f5es pelas quais recorremos a Oxy&#8217;Pharm h\u00e1 cerca de quinze anos atr\u00e1s.<\/p><\/blockquote>\n<p>[\/vc_column_text][vc_column_text]Pr. Alain Sarasin, Diretor de Investiga\u00e7\u00e3o no CNRS &#8211; Diretor do laborat\u00f3rio para o diagn\u00f3stico de doen\u00e7as infantis (Les enfants de la lune.) &#8211; Instituto Gustave Roussy, Villejuif[\/vc_column_text][vc_video link=&#8221;https:\/\/www.youtube.com\/watch?v=WrHhhT6RSN4&#8243;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text] Num laborat\u00f3rio que analisava os riscos de cancro, o facto de utilizar material considerado cancer\u00edgeno n\u00e3o era uma boa<\/p>\n","protected":false},"author":3,"featured_media":3056,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[133],"tags":[],"class_list":["post-9793","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tem-a-palavra"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pr. Alain Sarasin, Diretor de Investiga\u00e7\u00e3o no CNRS - Oxy&#039;Pharm<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pr. Alain Sarasin, Diretor de Investiga\u00e7\u00e3o no CNRS - Oxy&#039;Pharm\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_column_text] Num laborat\u00f3rio que analisava os riscos de cancro, o facto de utilizar material considerado cancer\u00edgeno n\u00e3o era uma boa\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/\" \/>\n<meta property=\"og:site_name\" content=\"Oxy&#039;Pharm\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=100065087790394\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-26T11:52:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-28T09:35:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"marketing\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@OxyPharm\" \/>\n<meta name=\"twitter:site\" content=\"@OxyPharm\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"marketing\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/\"},\"author\":{\"name\":\"marketing\",\"@id\":\"https:\/\/www.oxypharm.net\/#\/schema\/person\/4e54abf170588a0853a460e68ac97dc8\"},\"headline\":\"Pr. Alain Sarasin, Diretor de Investiga\u00e7\u00e3o no CNRS\",\"datePublished\":\"2022-09-26T11:52:01+00:00\",\"dateModified\":\"2025-04-28T09:35:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/\"},\"wordCount\":112,\"publisher\":{\"@id\":\"https:\/\/www.oxypharm.net\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg\",\"articleSection\":[\"Tem a Palavra!\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/\",\"url\":\"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/\",\"name\":\"Pr. Alain Sarasin, Diretor de Investiga\u00e7\u00e3o no CNRS - Oxy&#039;Pharm\",\"isPartOf\":{\"@id\":\"https:\/\/www.oxypharm.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg\",\"datePublished\":\"2022-09-26T11:52:01+00:00\",\"dateModified\":\"2025-04-28T09:35:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/#primaryimage\",\"url\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg\",\"contentUrl\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.oxypharm.net\/pt-pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pr. Alain Sarasin, Diretor de Investiga\u00e7\u00e3o no CNRS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.oxypharm.net\/#website\",\"url\":\"https:\/\/www.oxypharm.net\/\",\"name\":\"Oxy&#039;Pharm\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.oxypharm.net\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.oxypharm.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.oxypharm.net\/#organization\",\"name\":\"Oxy'pharm\",\"alternateName\":\"Oxypharm\",\"url\":\"https:\/\/www.oxypharm.net\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.oxypharm.net\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2023\/06\/Logo-Medtradex-Oxypharm.jpg\",\"contentUrl\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2023\/06\/Logo-Medtradex-Oxypharm.jpg\",\"width\":500,\"height\":500,\"caption\":\"Oxy'pharm\"},\"image\":{\"@id\":\"https:\/\/www.oxypharm.net\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=100065087790394\",\"https:\/\/x.com\/OxyPharm\",\"https:\/\/www.instagram.com\/oxy_pharm\/\",\"https:\/\/www.linkedin.com\/company\/oxy-pharm\/\",\"https:\/\/www.youtube.com\/channel\/UCwTjwWFZWcMdPPlvkTuiurw\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.oxypharm.net\/#\/schema\/person\/4e54abf170588a0853a460e68ac97dc8\",\"name\":\"marketing\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pr. Alain Sarasin, Diretor de Investiga\u00e7\u00e3o no CNRS - Oxy&#039;Pharm","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/","og_locale":"pt_PT","og_type":"article","og_title":"Pr. Alain Sarasin, Diretor de Investiga\u00e7\u00e3o no CNRS - Oxy&#039;Pharm","og_description":"[vc_row][vc_column][vc_column_text] Num laborat\u00f3rio que analisava os riscos de cancro, o facto de utilizar material considerado cancer\u00edgeno n\u00e3o era uma boa","og_url":"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/","og_site_name":"Oxy&#039;Pharm","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=100065087790394","article_published_time":"2022-09-26T11:52:01+00:00","article_modified_time":"2025-04-28T09:35:54+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg","type":"image\/jpeg"}],"author":"marketing","twitter_card":"summary_large_image","twitter_creator":"@OxyPharm","twitter_site":"@OxyPharm","twitter_misc":{"Written by":"marketing","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/#article","isPartOf":{"@id":"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/"},"author":{"name":"marketing","@id":"https:\/\/www.oxypharm.net\/#\/schema\/person\/4e54abf170588a0853a460e68ac97dc8"},"headline":"Pr. Alain Sarasin, Diretor de Investiga\u00e7\u00e3o no CNRS","datePublished":"2022-09-26T11:52:01+00:00","dateModified":"2025-04-28T09:35:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/"},"wordCount":112,"publisher":{"@id":"https:\/\/www.oxypharm.net\/#organization"},"image":{"@id":"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg","articleSection":["Tem a Palavra!"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/","url":"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/","name":"Pr. Alain Sarasin, Diretor de Investiga\u00e7\u00e3o no CNRS - Oxy&#039;Pharm","isPartOf":{"@id":"https:\/\/www.oxypharm.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/#primaryimage"},"image":{"@id":"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg","datePublished":"2022-09-26T11:52:01+00:00","dateModified":"2025-04-28T09:35:54+00:00","breadcrumb":{"@id":"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/#primaryimage","url":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg","contentUrl":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.oxypharm.net\/pt-pt\/pr-alain-sarasin-diretor-de-investigacao-no-cnrs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.oxypharm.net\/pt-pt\/"},{"@type":"ListItem","position":2,"name":"Pr. Alain Sarasin, Diretor de Investiga\u00e7\u00e3o no CNRS"}]},{"@type":"WebSite","@id":"https:\/\/www.oxypharm.net\/#website","url":"https:\/\/www.oxypharm.net\/","name":"Oxy&#039;Pharm","description":"","publisher":{"@id":"https:\/\/www.oxypharm.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oxypharm.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/www.oxypharm.net\/#organization","name":"Oxy'pharm","alternateName":"Oxypharm","url":"https:\/\/www.oxypharm.net\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.oxypharm.net\/#\/schema\/logo\/image\/","url":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2023\/06\/Logo-Medtradex-Oxypharm.jpg","contentUrl":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2023\/06\/Logo-Medtradex-Oxypharm.jpg","width":500,"height":500,"caption":"Oxy'pharm"},"image":{"@id":"https:\/\/www.oxypharm.net\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=100065087790394","https:\/\/x.com\/OxyPharm","https:\/\/www.instagram.com\/oxy_pharm\/","https:\/\/www.linkedin.com\/company\/oxy-pharm\/","https:\/\/www.youtube.com\/channel\/UCwTjwWFZWcMdPPlvkTuiurw"]},{"@type":"Person","@id":"https:\/\/www.oxypharm.net\/#\/schema\/person\/4e54abf170588a0853a460e68ac97dc8","name":"marketing"}]}},"_links":{"self":[{"href":"https:\/\/www.oxypharm.net\/pt-pt\/wp-json\/wp\/v2\/posts\/9793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oxypharm.net\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oxypharm.net\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oxypharm.net\/pt-pt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oxypharm.net\/pt-pt\/wp-json\/wp\/v2\/comments?post=9793"}],"version-history":[{"count":1,"href":"https:\/\/www.oxypharm.net\/pt-pt\/wp-json\/wp\/v2\/posts\/9793\/revisions"}],"predecessor-version":[{"id":10302,"href":"https:\/\/www.oxypharm.net\/pt-pt\/wp-json\/wp\/v2\/posts\/9793\/revisions\/10302"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oxypharm.net\/pt-pt\/wp-json\/wp\/v2\/media\/3056"}],"wp:attachment":[{"href":"https:\/\/www.oxypharm.net\/pt-pt\/wp-json\/wp\/v2\/media?parent=9793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oxypharm.net\/pt-pt\/wp-json\/wp\/v2\/categories?post=9793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oxypharm.net\/pt-pt\/wp-json\/wp\/v2\/tags?post=9793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}